Related Experiment Video
Updated: Nov 29, 2025
09:02
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
12.2K
Palliative care in onco-hematology: a perspective
Maria Eduarda Couto1, José Ferraz-Gonçalves2
1Onco-hematology Service, Instituto Português de Oncologia do Porto Francisco Gentil E.P.E., Porto, Portugal. eduarda.scouto@gmail.com.
Summary
Hematologic patients require specialized palliative care (PC) due to unique needs. Increased PC integration in hematology is crucial for better symptom management and support for these patients.
Area of Science:
- Oncology
- Palliative Care
- Hematology
Background:
- Palliative care (PC) focuses on symptom control and support for severe illnesses.
- Oncologic patients are the primary recipients of PC, while hematologic patients constitute only 7% of referrals.
- Hematologic patients present unique challenges in PC, including delayed referrals and advanced disease stages.
Purpose of the Study:
- To highlight the distinct needs of hematologic patients within palliative care.
- To advocate for increased integration of palliative care in hematology.
- To share experiences from an oncologic palliative care unit.
Main Methods:
- Commentary on palliative care in hematology.
- Review of evidence comparing PC in hematologic vs. other oncologic patients.
- Discussion of experiences from a specialized palliative care unit.
Main Results:
- Hematologic patients are under-referred to PC.
- These patients often present with advanced disease and significant symptomatology.
- There is a shorter interval between last treatment, referral, or death for hematologic patients.
Conclusions:
- Hematologic patients represent a distinct group requiring tailored PC approaches.
- Enhanced health education and policy changes are necessary to improve PC integration in hematology.
- Increased participation of specialized PC in hematology is essential.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.2K
09:52Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
13.7K
Related Concept Videos
01:25Continuing Care
1.7K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.7K
02:49Cancer Therapies
9.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.3K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
01:27Nursing Ethical Principles II
1.7K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.7K
01:20Overview of Hematopoiesis
7.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
7.0K
01:27Tumor Immunotherapy
922
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
922